Nithya Desikan is an Operating Partner at B-Flexion, bringing more than 22 years of experience in pharmaceuticals and biotech operations and executive management, commercializing novel therapies and building start-up organizations. As a fully integrated member of the investment team, she is responsible for leading aspects of diligence that require operational expertise, identification of growth opportunities, and partnering with companies to drive post-close value creation. Since joining B-Flexion, Nithya has been instrumental in the acquisition and transformation of Radius Health and Paratek Pharmaceuticals.

Prior to joining, Nithya was the Chief Operating Officer of Sionna Therapeutics, a company focused on development of novel therapies for Cystic Fibrosis. Prior to this role, she was the Chief Commercial Officer of Rhythm Pharmaceuticals from clinical-stage start-up to approval of their first product. Nithya joined Rhythm from Biogen, where in her 5-year tenure, she oversaw multiple launches and led cross-functional strategies for long-term value creation as Vice President and Asset Executive.

Nithya began her career with 12 years at Johnson & Johnson Company, launching brands in the US and abroad including: Xarelto®, Levaquin®, Topamax®, Ultracet®, and Velcade®.
‍

Ms. Desikan holds a BS in Material Science Engineering from the University of Florida.